227 related articles for article (PubMed ID: 20823139)
1. DNA repair: a reinvigorated therapeutic target.
Bates SE
Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
[No Abstract] [Full Text] [Related]
2. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
Montagnoli A; Moll J; Colotta F
Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
[TBL] [Abstract][Full Text] [Related]
3. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
Kashkar H
Clin Cancer Res; 2010 Sep; 16(18):4496-502. PubMed ID: 20682709
[TBL] [Abstract][Full Text] [Related]
4. [G-protein-coupled receptors, the beginning of a new era for therapeutic innovation].
Bril A; Combettes M; Audinot V
Med Sci (Paris); 2012 Oct; 28(10):799-800. PubMed ID: 23067404
[No Abstract] [Full Text] [Related]
5. Epigenetic deregulation of DNA repair and its potential for therapy.
Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
[TBL] [Abstract][Full Text] [Related]
6. DNA repair as treatment target.
Helleday T
Eur J Cancer; 2011 Sep; 47 Suppl 3():S333-5. PubMed ID: 21944004
[No Abstract] [Full Text] [Related]
7. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
8. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
Plummer R
Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
[TBL] [Abstract][Full Text] [Related]
9. The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.
Barry JJ; Jian BJ; Sughrue ME; Kane AJ; Mills SA; Tihan T; Parsa AT
Neurosurgery; 2011 Jan; 68(1):231-40; discussion 240-1. PubMed ID: 21099719
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies in oncology--a challenge for clinical and academic pathology].
Röcken C
Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265
[No Abstract] [Full Text] [Related]
11. Targeted therapy for thyroid cancer: An updated review of investigational agents.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
[TBL] [Abstract][Full Text] [Related]
12. [Breakthroughs in cancer treatment].
Rørth M
Ugeskr Laeger; 2011 Jun; 173(24):1721-4. PubMed ID: 21696676
[TBL] [Abstract][Full Text] [Related]
13. The next generation of antibody-drug conjugates comes of age.
Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
[TBL] [Abstract][Full Text] [Related]
14. [TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
Foughali R; Marie JC
Med Sci (Paris); 2020 Jan; 36(1):77-79. PubMed ID: 32014103
[No Abstract] [Full Text] [Related]
15. Successes and limitations of targeted cancer therapy in ovarian cancer.
Damia G; Sessa C
Prog Tumor Res; 2014; 41():89-97. PubMed ID: 24727989
[TBL] [Abstract][Full Text] [Related]
16. [Meningeal lymphatics, a potential target for the treatment of brain tumors].
Thomas JL; Song E; Boisserand L; Iwasaki A
Med Sci (Paris); 2020; 36(8-9):709-713. PubMed ID: 32821046
[TBL] [Abstract][Full Text] [Related]
17. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Eisenhauer EA; Seymour LK
Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
[TBL] [Abstract][Full Text] [Related]
18. DNA Damage Response as a Pharmacological Target for Cancer and Infectious Diseases.
Poplawski T
Curr Med Chem; 2019; 26(8):1423-1424. PubMed ID: 31189460
[No Abstract] [Full Text] [Related]
19. Integrating novel therapies into the treatment of sarcoma: a multidisciplinary approach--introduction.
D'Adamo DR
Semin Oncol; 2011 Oct; 38 Suppl 3():S1-2. PubMed ID: 22055967
[No Abstract] [Full Text] [Related]
20. Biomarkers as molecular targets of drug interventions.
Smith JJ; Dunn BK
Semin Oncol Nurs; 2012 May; 28(2):109-15. PubMed ID: 22542318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
